Navigation Links
Covis Pharmaceuticals, Inc Named US Distributor For Five Additional Products
Date:4/5/2013

CARY, N.C., April 5, 2013 /PRNewswire/ -- Covis Pharmaceuticals, Inc. announced an agreement today to distribute Nilandron® (nilutamide), Plaquenil® (hydroxychloroquine), Rilutek® (riluzole), Uroxatral® (alfuzosin hydrochloride) and Kayexalate® (sodium polystyrene sulfate) in the United States.

The products cover a broad array of treatments and disease states:  Nilandron is used to treat prostate cancer; Plaquenil is an anti-malarial drug; Rilutek treats amyotrophic lateral sclerosis; Uroxatral is used to treat Benign Prostatic Hyperplasia (BPH); and, Kayexalate is prescribed to remove dangerously high levels of potassium in the blood.  With the addition of these products, Covis Pharmaceuticals, Inc. will be distributing 11 brands in the United States.  As part of their mission to ensure availability and access to all products, Covis will continue to offer a patient assistance program

"This agreement underscores our commitment to provide patients with a continuous supply of safe and efficacious therapeutic solutions," said Bill Collins , Chief-Executive-Officer of Covis.  "These additional products will allow Covis to broaden our portfolio with consistent, top quality branded pharmaceuticals."  

The company's current product portfolio includes Lanoxin® (digoxin) Tablets, Lanoxin® (digoxin) IV, Parnate® (tranylcypromine sulfate tablets), Zantac® (ranitidine hydrochloride) Injection, Fortaz® (ceftazidime for injection) and Zinacef® (cefuroxime for injection).  For full prescribing information on these Covis products, including boxed warnings for Parnate®, please visit www.covispharma.com or contact the Company at 919-535-3049.  For full prescribing information on Nilandron Tablets, Plaquenil Tablets, Rilutek Tablets, Uroxatral Tablets, and Kayexalate Powder, including boxed warnings for Nilandron and Plaquenil, please visit http://dailymed.nlm.nih.gov.

Fortaz®, Zinacef®, Lanoxin®, and Parnate® are registered trademarks of the GlaxoSmithKline group of companies. Zantac® is a registered trademark of Boehringer Ingelheim Pharmaceuticals, Inc., used under license.

About Covis Pharmaceuticals, Inc.   
Covis Pharmaceuticals is a specialty pharmaceutical distributor dedicated to improving the lives of people with life-threatening conditions and chronic illnesses. It is our mission to provide our customers with a continuous supply of safe and efficacious therapeutic solutions. The Website is: www.covispharma.com.


'/>"/>
SOURCE Covis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
2. Provectus Pharmaceuticals, Inc.s Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
3. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
4. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
5. Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care Conference
6. Depomed Announces Receipt of $1 million Milestone Payment From Ironwood Pharmaceuticals, Inc.
7. Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering Testim
8. Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
9. Auxilium Pharmaceuticals, Inc. to Present at the Goldman Sachs Global Healthcare Conference 2012
10. Hybrid Fuels, Inc. Announces Name Change to Nouveau Life Pharmaceuticals, Inc.
11. Debiopharm and Ascepion Pharmaceuticals, Inc. Announce an Exclusive License Agreement for the Development and Commercialisation of the Dual-Targeting Kinase Inhibitor, ASP-08126 (Debio 1144), for the Treatment of Oncology Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... The global  pacemaker market  is expected to reach USD 12.3 billion ... heightening prevalence of cardiac conditions coupled with the availability of medical coverage is ... enhancements in these devices are supporting the expansion of this vertical. ... ... Grand View Research Logo ...
(Date:1/19/2017)... -- ViewRay, Inc. (Nasdaq: VRAY ), makers ... radiation therapy system, announced today that it has raised ... a private placement of its common stock and ... was joined by certain of ViewRay,s existing investors, ... and an additional new institutional investor, Acuta Capital ...
(Date:1/19/2017)...  Magnetic Insight Inc., leader in magnetic particle ... with inviCRO LLC to develop intuitive image analysis ... on inviCRO,s VivoQuant™ visualization and post processing software ... MPI solution package with the Momentum MPI imaging ... in vivo. MPI is a groundbreaking ...
Breaking Medicine Technology:
(Date:1/20/2017)... ... ... “Knowledge is God’s Lighthouse”: a moving and colorful collection of prayers that reminds ... published author, Gene Gaapf, a retired truck driver, and a long-time writer, whose published ... high school and have many different titles,” Gaapf mentions about his different works. “I ...
(Date:1/20/2017)... ... January 20, 2017 , ... “God's Miracle Man: Against All ... is the creation of published author, Keith C. A. Tucker, son of Minister Delores ... World Outreach pastured by Reverend Mark Hardy , “While sitting up in bed, I ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... On-demand E-learning system for Clinical and Regulatory education for Physicians, Physician Advisors, ... Aerolib`s successful education methodology of Disease Specific Documentation Improvement. , The Aerolib ...
(Date:1/19/2017)... ... January 19, 2017 , ... Wells Pharmacy Network announced the ... 503A compounding pharmacy located in Ocala, Florida. , Meeting the Needs of ... the United States for high-quality human anti-aging and wellness compounded medications, ...
(Date:1/19/2017)... Beach, Florida (PRWEB) , ... January 19, 2017 , ... ... J.D., LCSW, announced that the name of their drug rehab center in Delray Beach, ... time we recognize that not only stars such as Philip Seymour Hoffman and Chris ...
Breaking Medicine News(10 mins):